MC2306A1 - Peptides bloquant les infections par le virus de l'immunodeficience humaine et methode de leur utilisation - Google Patents

Peptides bloquant les infections par le virus de l'immunodeficience humaine et methode de leur utilisation

Info

Publication number
MC2306A1
MC2306A1 MC912306D MC2306D MC2306A1 MC 2306 A1 MC2306 A1 MC 2306A1 MC 912306 D MC912306 D MC 912306D MC 2306 D MC2306 D MC 2306D MC 2306 A1 MC2306 A1 MC 2306A1
Authority
MC
Monaco
Prior art keywords
methods
immunodeficiency virus
human immunodeficiency
virus infections
peptides
Prior art date
Application number
MC912306D
Other languages
English (en)
Inventor
Anders Vahle
Bo Rymo Lars Svennerholm
Stig Jeansson
Peter Horal
Original Assignee
Syntello Vaccine Dev Kb
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Syntello Vaccine Dev Kb filed Critical Syntello Vaccine Dev Kb
Publication of MC2306A1 publication Critical patent/MC2306A1/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/28—Materials for coating prostheses
    • A61L27/34—Macromolecular materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06139—Dipeptides with the first amino acid being heterocyclic
    • C07K5/06165—Dipeptides with the first amino acid being heterocyclic and Pro-amino acid; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0802—Tripeptides with the first amino acid being neutral
    • C07K5/0804—Tripeptides with the first amino acid being neutral and aliphatic
    • C07K5/0806—Tripeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atoms, i.e. Gly, Ala
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1019—Tetrapeptides with the first amino acid being basic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Virology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Dermatology (AREA)
  • Transplantation (AREA)
  • Epidemiology (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
MC912306D 1990-08-22 1991-08-20 Peptides bloquant les infections par le virus de l'immunodeficience humaine et methode de leur utilisation MC2306A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US57108090A 1990-08-22 1990-08-22

Publications (1)

Publication Number Publication Date
MC2306A1 true MC2306A1 (fr) 1993-09-27

Family

ID=24282265

Family Applications (1)

Application Number Title Priority Date Filing Date
MC912306D MC2306A1 (fr) 1990-08-22 1991-08-20 Peptides bloquant les infections par le virus de l'immunodeficience humaine et methode de leur utilisation

Country Status (17)

Country Link
EP (1) EP0545991B1 (fr)
JP (1) JP3115596B2 (fr)
KR (1) KR100220531B1 (fr)
AT (1) ATE173934T1 (fr)
AU (1) AU667290B2 (fr)
BR (1) BR9106772A (fr)
CA (1) CA2088788C (fr)
DE (1) DE69130571T2 (fr)
DK (1) DK0545991T3 (fr)
ES (1) ES2128322T3 (fr)
FI (1) FI930519A (fr)
GR (1) GR3029523T3 (fr)
HU (1) HUT63177A (fr)
MC (1) MC2306A1 (fr)
NO (1) NO930401L (fr)
OA (1) OA10051A (fr)
WO (1) WO1992003147A1 (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007080194A2 (fr) * 2006-01-13 2007-07-19 Oncoreg Ab Utilisation de composés en combinaison avec l'irradiation gamma pour le traitement du cancer
FR2925501B1 (fr) * 2007-12-21 2012-12-14 Vincience Peptide activateur de la synthese des aquaporines et composition cosmetique et/ou pharmaceutique le contenant
FR2925500B1 (fr) * 2007-12-21 2011-05-06 Vincience Peptide derive d'une proteine de la famille des aquaporines et composition cosmetique et/ou pharmaceutique le contenant

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1987002775A1 (fr) * 1985-10-24 1987-05-07 Southwest Foundation For Biomedical Research Peptides synthetiques et leur utilisation pour le diagnostic et la vaccination contre le sida et son complexe associe
NL8702403A (nl) * 1987-10-09 1989-05-01 Stichting Centr Diergeneeskund Oligopeptiden en gebruik daarvan voor diagnostische en vaccinatiedoeleinden voor aids en arc.

Also Published As

Publication number Publication date
GR3029523T3 (en) 1999-06-30
ATE173934T1 (de) 1998-12-15
CA2088788C (fr) 2003-12-16
FI930519A0 (fi) 1993-02-05
OA10051A (en) 1996-10-14
ES2128322T3 (es) 1999-05-16
DE69130571D1 (de) 1999-01-14
BR9106772A (pt) 1993-07-20
JP3115596B2 (ja) 2000-12-11
NO930401L (no) 1993-02-17
CA2088788A1 (fr) 1992-02-23
EP0545991B1 (fr) 1998-12-02
AU8433291A (en) 1992-03-17
KR100220531B1 (ko) 1999-10-01
NO930401D0 (no) 1993-02-05
HUT63177A (en) 1993-07-28
AU667290B2 (en) 1996-03-21
DE69130571T2 (de) 1999-06-17
EP0545991A1 (fr) 1993-06-16
FI930519A (fi) 1993-04-21
JPH06504035A (ja) 1994-05-12
DK0545991T3 (da) 1999-08-16
HU9300456D0 (en) 1993-05-28
WO1992003147A1 (fr) 1992-03-05

Similar Documents

Publication Publication Date Title
ATE264914T1 (de) Antivirale proteine, dafür kodierende dna, und deren verwendung
TNSN91029A1 (fr) Les analogues du nucleoside de 1,3-oxathiolane
HK1060847A1 (en) Recombinant raccoon pox viruses and their use as an effective vaccine against feline immunodeficiency virus infection
RU94022480A (ru) Способ лечения гепатита, композиция, усиливающая ин виво инактивацию вируса гепатита с, препарат для лечения гепатита с
DE69131200D1 (en) Herpes simplex virus vp16 impfstoffe
HUP0202502A2 (hu) Virális fertőzőképességet blokkoló peptidek és eljárások ezek alkalmazására
DE69433007D1 (de) Peptide zum induzieren einer antwort der zytotoxischen t-lymphozyten gerichtet gegen das hepatitis b virus
BG98522A (en) Peptides including cytotoxic t-lymphocytic response to the virus of hepatite b
EP0616535A4 (fr) Procede de traitement d'infections virales.
EA199800526A1 (ru) Производные бензимидазола и их применение для лечения вирусных инфекций
ATE169822T1 (de) Behandlung von herpesvirus infektion
MC2306A1 (fr) Peptides bloquant les infections par le virus de l'immunodeficience humaine et methode de leur utilisation
FI944561A0 (fi) HIV:tä neutraloivia monoklonaalisia yhdistelmähumaanivasta-aineita HIV-infektion ehkäisemiseksi ja hoitamiseksi
AU2880595A (en) Use of pharmaceutical agents for restoring, alleviation, or treatment of immunodeficiency, including the alleviation or treatment of the immune dysfunction related to infection with human immunodeficiency viruses (hiv) or related viruses
DK720588A (da) Forbindelser til anvendelse ved behandling eller forebyggelse af human-immundefektvirus-(hiv)-infektion, og farmaceutiske praeparater indeholdende samme
PL326629A1 (en) Application of flupyrtin in prophylaxy and therapy of deseases associated with damaged hematopoietic cellular system
ES2162862T3 (es) Uso de la timosina para tratar la hepatitis c en pacientes que no responden al tratamiento con interferon.
ITMI913493A1 (it) Dispositivo per la disinfezione o la immunizzazione di zone del corpo umano esposte al contagio, da germi, batteri e virus
RU93005034A (ru) Пептиды, блокирующие инфекцию вируса иммунодефицита человека, способы их применения
HUP0100937A2 (hu) Többszörösen elágazó peptidkonstrukciókat tartalmazó liposzómák és alkalmazásuk humán immundeficiencia vírus ellen
EA199700353A1 (ru) Композиция и способ для определения приобретенного синдрома иммунодефицита, способ приготовления названной композиции
EP1143981A4 (fr) Traitement et prevention d'infections par le vih et d'autres infections virales
EP0247873A3 (fr) Bactériocines et compositions les contenant pour le traitement antiviral
AU2880495A (en) Use of pharmaceutical agents for alleviation or treatment of the immune dysfunction related to infection with human immunodeficiency viruses (hiv) or related viruses
ES8605576A1 (es) Un procedimiento para preparar una composicion contra infecciones virales de hepatitis b